Related references
Note: Only part of the references are listed.ASK1 inhibition: a therapeutic strategy with multi-system benefits
Jacqueline M. Ogier et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors
Zhili Xin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2020)
A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction
Saktimayee M. Roy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice
Jiayi Zhao et al.
SCIENTIFIC REPORTS (2019)
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors
Martin K. Himmelbauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders
So Yeong Cheon et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death
Stephanie B. Syc-Mazurek et al.
CELL DEATH & DISEASE (2018)
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure
Marion Lanier et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis
Takao Fujisawa et al.
HUMAN MOLECULAR GENETICS (2016)
Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models
Snahel Patel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Apoptosis signal-regulating kinase 1 as a therapeutic target
Yosuke Kawarazaki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst
Jocelyn M. Madeira et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease
Paul D. Wes et al.
PLOS ONE (2014)
In Vitro P-glycoprotein Efflux Ratio Can Predict the In Vivo Brain Penetration Regardless of Biopharmaceutics Drug Disposition Classification System Class
Ryota Kikuchi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Species Independence in Brain Tissue Binding Using Brain Homogenates
Li Di et al.
DRUG METABOLISM AND DISPOSITION (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway
Xiaoli Guo et al.
EMBO MOLECULAR MEDICINE (2010)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity
A Matsuzawa et al.
NATURE IMMUNOLOGY (2005)
Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation
K Takeda et al.
EMBO REPORTS (2004)
The ASK1-MAP kinase cascades in mammalian stress response
J Matsukawa et al.
JOURNAL OF BIOCHEMISTRY (2004)
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
H Nishitoh et al.
GENES & DEVELOPMENT (2002)
Share Paper
